You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

muscle-invasive bladder cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • Cystoscopy
    • +2 more
    • (no location specified)
    Apr 4, 2023

    Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

    Recruiting
    • Non Muscle Invasive Bladder Cancer
    • N803 plus Bacillus Calmette-Guerin (BCG)
    • Honolulu, Hawaii
      Island Urology
    Aug 7, 2023

    Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

    Completed
    • Urinary Bladder Cancer
    • +4 more
    • Neutrophil to lymphocyte ratio
    • Cairo, Egypt
      Ain Shams university
    Jul 15, 2023

    Non-muscle Invasive Bladder Cancer Trial (TARA-002)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • TARA-002
    • (no location specified)
    Jul 14, 2023

    Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

    Recruiting
    • Bladder Cancer
    • Pseudomonas aeruginosa
    • Jinan, Shandong, China
      Qilu hospital
    Jul 26, 2023

    Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, AK104)

    Recruiting
    • Muscle Invasive Bladder Carcinoma
    • Beijing, China
      Cancer Institute and Hospital, Chinese Academy of Medical Scienc
    Oct 6, 2023

    BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

    Recruiting
    • Bladder Cancer
      • Little Rock, Arkansas
      • +2 more
      Aug 6, 2023

      Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

      Not yet recruiting
      • Non-Muscle- Invasive Bladder Cancer
      • Durvalumab
      • BCG
      • (no location specified)
      Jul 5, 2023

      Bladder Cancer Trial in Tianjin (Cadonilimab)

      Recruiting
      • Bladder Cancer
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Aug 23, 2023

      Predicting Post-cystectomy Outcome in Muscle Invasive Bladder

      Recruiting
      • Bladder Cancer
      • develop and validate a deep learning radiomics model based on preoperative enhanced CT image
      • Chongqing, Chongqing, China
        Department of Urology, The First Affiliated Hospital of Chongqin
      Oct 18, 2023

      Mood Alterations in Non-Muscle Invasive Bladder Cancer Treated

      Recruiting
      • Non-Muscle Invasive Bladder Cancer
      • Questionnaires
      • +4 more
      • Washington, District of Columbia
        Sibley Memorial Hospital
      Jan 17, 2023

      Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

      Not yet recruiting
      • Muscle-Invasive Bladder Carcinoma
      • +2 more
      • Guangzhou, Guangdong, China
        Cancer Center, Sun Yat-sen University
      Aug 3, 2023

      Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

      Not yet recruiting
      • Non-Muscle Invasive Bladder Cancer
      • +4 more
      • Behavioral: Motivational Interviewing with WhatsApp video call
      • Istanbul, Turkey
        İrem Nur Ozdemir
      Jan 20, 2023

      ctDNA in Muscle-invasive Bladder Cancer Treated With Trimodality

      Recruiting
      • Bladder Cancer
      • Muscle-Invasive Bladder Carcinoma
        • Chapel Hill, North Carolina
          North Carolina Cancer Hospital (UNC)
        Jan 11, 2023

        Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

        Active, not recruiting
        • Non-muscle-invasive Bladder Cancer
        • Gemcitabine 1000 mg, Docetaxel 37.5g
        • Zagreb, Croatia
          University Hospital Centre Zagreb
        Jan 20, 2023

        Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy

        Recruiting
        • Muscle-Invasive Bladder Carcinoma
        • +2 more
        • cisplatin based neoadjuvant chemotherapy
        • Radical cystectomy alone
        • Rome, Italy
          Riccardo Mastroianni
        Mar 8, 2023

        Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

        Recruiting
        • Non-muscle-invasive Bladder Cancer
        • Cairo, Egypt
          Mohamed Fawzy Salman
        Nov 19, 2022

        Toxicity Trial in Ghent (Adjuvant EBRT)

        Completed
        • Toxicity
        • Adjuvant EBRT
        • Ghent, Belgium
          Dept of Radiotherapy, University Hospital Ghent
        Dec 23, 2022

        Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

        Not yet recruiting
        • Non Muscle Invasive Bladder Cancer
        • +3 more
        • Cretostimogene Grenadenorepvec
        • n-dodecyl-B-D-maltoside
        • (no location specified)
        Oct 30, 2023

        Bladder Cancer Stage II Trial in Los Angeles (MRI imaging of the pelvis/bladder, genomic analysis of tumor)

        Recruiting
        • Bladder Cancer Stage II
        • MRI imaging of the pelvis/bladder
        • genomic analysis of tumor
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Sep 27, 2022

        Analytical Specificity of Bladder EpiCheck Test in Healthy

        Completed
        • Non Muscle Invasive Bladder Cancer
        • Non-Muscle Invasive Bladder Urothelial Carcinoma
        • Bladder EpiCheck
        • San Antonio, Texas
          Urology San Antonio
        Sep 3, 2023

        Uromonitor asBiomarker for Optimization of NMIBC Management by

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
          • (no location specified)
          May 9, 2023